CORT Prakiraan wutah bathi kanggo taun ngarep corcept.com
Corcept Therapeutics (CORT) relies on the high margins of mifepristone and outsourced production. The projected change in earnings per share for the coming year demonstrates the market consensus, where the 113.20 mark reflects the latest data. A reputation as an endocrinology innovator is complemented by a strong team of biochemists and experts in bringing orphan drugs to market, ensuring stable business development.
CORT (Corcept Therapeutics Inc.): rincian analitis lan laporan miturut indikator
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- indikator kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Corcept Therapeutics|CORT - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Corcept Therapeutics Corp|CORT - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Corcept|CORT - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Corcept Therapeutics|Likuiditas cepet corcept.com
- data bathi resik lan rasio valuasi:
CORT - Penghasilan resik perusahaan|Bathi sing dikarepake Corcept Therapeutics|CORT - Nilai perusahaan marang bathi resik|Pangali Forward P/E Corcept Therapeutics Inc.|CORT - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Corcept Therapeutics|CORT - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Corcept Therapeutics|CORT - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan corcept.com|CORT - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Corcept Therapeutics
- data total pendapatan lan volume dodolan:
Analisis wiwitan perusahaan:CORT, corcept.com
This indicator measures the market's weighted average expectation for earnings per share in the next period, determining the asset's fair value through future cash flows. By analyzing this chart of the EPS n+1 consensus forecast trend, an investor assesses the stability of Corcept Therapeutics (CORT), where patent protection for endocrine drugs guarantees predictable income and minimizes the risk of overpaying for the business.
Analisis perusahaan pesaing
ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep RYTM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AKRO (Akero Therapeutics, Inc.)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep metsera.com MTSR|MoonLake Corp (MLTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|CRNX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|SLNO: Prakiraan wutah bathi kanggo taun ngarep|FOLD - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep 89bio Pharma|Agios Corp (AGIO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep structuretx.com (GPCR)|Prakiraan wutah bathi saben saham kanggo taun ngarep mimedx.com MDXG|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MBX: Prakiraan wutah bathi saben saham kanggo taun ngarep|Altimmune Corp - Proyeksi tambahing bathi saben saham ing taun ngarep|Aardvark Therapeutics Inc (AARD) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Biomea Fusion (BMEA)|Prakiraan wutah bathi kanggo taun ngarep QNCX|Proyeksi tambahing bathi saben saham ing taun ngarep GUTS|Prakiraan wutah bathi kanggo taun ngarep VTVT (vTv Therapeutics Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluristem Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep synlogictx.com SYBX|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Matinas BioPharma Holdings, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences Inc.) - Prakiraan wutah bathi kanggo taun ngarep|galecto.com (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep organovo.com ONVO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep
